Skip to content

UPDATE: We are delighted to announce that EPSRC have funded our CDT for five more years under the new name EPSRC Centre for Doctoral Training in Intelligent Integrated Imaging in Healthcare (i4health).

Visit our new website at:

Dr David Werring

UCL Institute of Neurology

Box 6
UCL Institute of Neurology

Tel: 020 7829 8753

Fax: 020 7833 8613


Dr Werring is a clinical neurologist and researcher leading a research program into stroke, with a particular interest in neuroimaging and small vessel disease, focussing on intracerebral haemorrhage including cerebral amyloid angiopathy. Cerebral amyloid angiopathy is a key cause of cerebral haemorrhage and dementia. Dr Werring is Chief Investigator for the CROMIS-2 (Clinical Relevance of Microbleeds in Stroke) study (, and for studies of new imaging biomarkers for cerebral amyloid antipathy. Research methods include cross sectional and prospective cohort studies, MRI techniques, neuropsychological profiling, CSF biomarkers and neurogenetics.

IRIS Profile